Polydex Reports Second Quarter Financial Results Sales continue to grow, up 3% from 2016 2nd Quarter 43% increase in Gross Profits over same period last year TORONTO, Sept. 15, 2016 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC...

Polydex Pharmaceuticals Issues First Quarter Financial Results TORONTO, June 14, 2016 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2017, the period ending April...

Polydex Pharmaceuticals Provides Year End Financial Report Three Full Years of Sustained Profitability Net Income Doubles Over Last Year TORONTO, May 02, 2016 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) reports...

Polydex Pharmaceuticals Ltd. Files OTC Market Disclosure Documents TORONTO, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) announces the filing of all of the required disclosure statements in order to be considered as providing...

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results Announcing a 9% Increase in Sales and 300% Increase in Net Income Eleven Consecutive Quarters with Sustained Profitability Conservation Practices to Reduce Utilities Expenses TORONTO, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC...